z-logo
open-access-imgOpen Access
Defense mechanisms against cadmium toxicity. III. Effects of pretreatment with a small oral dose of cadmium on metallothionein synthesis after a large oral dose of cadmium in mice.
Author(s) -
Shigeru Morita
Publication year - 1984
Publication title -
japanese journal of pharmacology/japanese journal of pharmacology
Language(s) - English
Resource type - Journals
eISSN - 1347-3506
pISSN - 0021-5198
DOI - 10.1254/jjp.35.153
Subject(s) - metallothionein , cadmium , kidney , chemistry , toxicity , pharmacology , intestinal mucosa , medicine , endocrinology , biology , organic chemistry
Pretreatment of female mice with a small oral dose of Cd2+ (15 mg Cd2+/kg) decreased Cd2+ uptake by the liver and kidney and increased that by the small intestinal mucosa at 4 or 24 hr after challenge with a large oral dose of Cd2+ (100 mg Cd2+/kg). By 4 hr after the challenge dose, more Cd2+ taken up by the liver was bound to metallothionein (MT) in the Cd2+-pretreated mice than the water-pretreated controls (10 ml H2O/kg); but at 24 hr, the amount of Cd2+ bound to MT in the liver and kidney were lower in the former than the latter. The amount of Cd2+ not bound to MT in the liver at 4 and 24 hr after the challenge dose and that in the kidney at 24 hr were lower in the Cd2+-pretreated mice than the water-pretreated controls. These results suggested that the factor directly related to the toxic action of Cd2+ was the amount of Cd2+ not associated with MT in the liver and other organs. More Cd2+ taken up by the small intestinal mucosa at 24 hr after the challenge dose was associated with MT in the Cd2+-pretreated mice than the water-pretreated controls. The present study indicates that MT induced in the small intestinal mucosa by pretreatment prevents Cd2+ absorption by sequestering subsequently administered Cd2+, and Cd2+ taken up by the liver and kidney is bound to MT in an inert form, thus the decrease in the amount of Cd2+ not bound to MT, giving protection from the acute oral toxicity of the cation. Pretreatment 24 hr prior to the challenge dose was found to be the most effective.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here